As part of the Heard at HLTH video series, MedCity News Editor in Chief Arundhati Parmar and Senior Reporter Katie Adams interviewed healthcare executives about innovations in health tech at HLTH 2023 in Las Vegas earlier this month.
Kidney care in the U.S. needs an overhaul. Changing today’s expensive, disconnected care model requires moving from volume to value.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
A federal judge blocked a bill that would have prevented dialysis clinics from steering patients to commercial insurance plans.
CVS Health's new HemoCare device would open up the at-home market for hemodialysis, which uses an artificial kidney device to perform the procedure and has traditionally been difficult to provide outside of a clinical setting.
The companies said the new price was due to a decline in the financial status of the medical group, along with a desire to expedite the process of obtaining clearance from the Federal Trade Commission.
DaVita HealthCare Partners has acquired dialysis operator Renal Venture for $415 million.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
The tension between accomplishing some of the aims of Obamacare to reduce healthcare costs and the diminishing number of physician practices is giving way to a certain amount of experimentation with healthcare business models. In the latest example, Independence Blue Cross and DaVita’s physician practice arm have collaborated to launch a new business called Tandigm […]